SS
ALXO icon

SBI Securities’s ALX Oncology ALXO Stock Holding History

SBI Securities’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29 Hold
14
– – ﹤0.01% 3774
2026
Q1 		$28 Sell
14
-398
-97% -$758 ﹤0.01% 3688
2025
Q4 		$466 Sell
412
-10
-2% -$15 ﹤0.01% 2895
2025
Q3 		$772 Hold
422
– – ﹤0.01% 2798
2025
Q2 		$175 Buy
422
+296
+235% +$149 ﹤0.01% 3355
2025
Q1 		$79 Buy
126
+104
+473% +$125 ﹤0.01% 3522
2024
Q4 		$37 Buy
+22
New +$34 ﹤0.01% 3695

Other funds holding ALXO

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
JF
JSF Financial Los Angeles, California $632M AUM 27.63% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

SBI Securities's ALXO Position: Q2 2026 in Review

SBI Securities held its ALX Oncology (ALXO) position steady in Q2 2026 at 14 shares worth $29. The position accounts for ﹤0.01% of the portfolio, ranked #3774.

SBI Securities first reported a position in ALXO in Q4 2024 and has held it in 7 quarters since. The position peaked at $772 in Q3 2025. 10 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

  • SBI Securities held 14 shares of ALX Oncology worth $29 as of Q2 2026.
  • SBI Securities left its ALX Oncology share count unchanged in Q2 2026.
  • ALX Oncology made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3774 holding.
  • SBI Securities first reported a position in ALX Oncology in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's ALX Oncology position peaked at $772 in Q3 2025.
  • 10 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.